Holdings
47
Concentrated
Top 10 weight
55%
Concentration
Active share
-
Style
Equity
100%
Asset allocation
Portfolio
-Sectors
5High-conviction bets
-Top sector wt.
0.0%Cash
Market-cap allocation
Large cap39%
Mid cap25%
Small cap5%
Asset allocation
Equity100%
Top holdings
11.0%
ELI LILLY & COEQUITY
6.9%5.7%
5.2%
Divi's Laboratories Ltd.EQUITY
5.1%Cipla Ltd.EQUITY
4.8%4.4%
JOHNSON & JOHNSONEQUITY
4.4%Lupin Ltd.EQUITY
3.6%Laurus Labs Ltd.EQUITY
3.5%ABBVIE INCEQUITY
3.2%Fortis Healthcare Ltd.EQUITY
3.1%3.1%
Aurobindo Pharma Ltd.EQUITY
2.7%MERCK & CO.INCEQUITY
2.3%NOVARTIS AGEQUITY
2.0%2.0%
Biocon Ltd.EQUITY
1.8%Mankind Pharma Ltd.EQUITY
1.7%IPCA Laboratories Ltd.EQUITY
1.6%Alkem Laboratories Ltd.EQUITY
1.5%AMGEN INCEQUITY
1.4%Zydus Lifesciences Ltd.EQUITY
1.4%1.3%
Gland Pharma Ltd.EQUITY
1.2%1.2%
Aster DM Healthcare Ltd.EQUITY
1.2%ABBOTT LABORATORIESEQUITY
1.1%GILEAD SCIENCES INCEQUITY
1.1%Novo Nordisk A/SEQUITY
1.1%INTUITIVE SURGICAL INCEQUITY
1.0%Ajanta Pharma Ltd.EQUITY
1.0%0.9%
DANAHER CORPEQUITY
0.9%0.8%
STRYKER CORPEQUITY
0.8%MEDTRONIC PLCEQUITY
0.7%Global Health Ltd.EQUITY
0.7%0.6%
0.5%
Anthem Biosciences Ltd.EQUITY
0.4%BECTON DICKINSON AND COEQUITY
0.3%AGILENT TECHNOLOGIES INCEQUITY
0.3%WATERS CORPEQUITY
0.3%IQVIA HOLDINGS INCEQUITY
0.2%Clearing Corporation of India Ltd.CASH_EQUIVALENT
0.2%Net Receivables/(Payables)CASH_EQUIVALENT
0.1%AI Smart summary
Pros
- Balanced across the metrics we track.
Cons
- No major structural red flags.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in this category.
No peers found in this category.
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
53.7%
16.7%
16.2%
6.6%
4.8%
1.8%